Boos CJ - Search Results

1

Antithrombotic treatment in atrial fibrillation.

Lip GY, Boos CJ. Lip GY, et al. Among authors: boos cj. Heart. 2006 Feb;92(2):155-61. doi: 10.1136/hrt.2005.066944. Epub 2005 Sep 13. Heart. 2006. PMID: 16159980 Free PMC article. Review.

2

Confounding factors in rate versus rhythm control trials in patients with atrial fibrillation: lessons from the strategies of treatment of atrial fibrillation (STAF) pilot study.

Carlsson J, Boos C. Carlsson J, et al. Card Electrophysiol Rev. 2003 Jun;7(2):122-6. doi: 10.1023/a:1027499114087. Card Electrophysiol Rev. 2003. PMID: 14618034 Review.

3

Rate or rhythm control in persistent atrial fibrillation?

Boos CJ, Carlsson J, More RS. Boos CJ, et al. QJM. 2003 Dec;96(12):881-92. doi: 10.1093/qjmed/hcg147. QJM. 2003. PMID: 14631054 Review.

4

A short course of oral amiodarone improves sinus rhythm maintenance post-cardioversion for atrial fibrillation.

Boos C, Ritzema J, More RS. Boos C, et al. Heart. 2004 Sep;90(9):1063-4. doi: 10.1136/hrt.2003.022665. Heart. 2004. PMID: 15310707 Free PMC article. No abstract available.

5

Novel therapies for the prevention of stroke.

Boos CJ, Lip GY. Boos CJ, et al. Expert Opin Investig Drugs. 2004 Dec;13(12):1615-30. doi: 10.1517/13543784.13.12.1615. Expert Opin Investig Drugs. 2004. PMID: 15566318 Review.

6

Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension?

Boos CJ, Lip GY. Boos CJ, et al. J Hum Hypertens. 2005 Jul;19(7):511-3. doi: 10.1038/sj.jhh.1001858. J Hum Hypertens. 2005. PMID: 15905894 Review. No abstract available.

7

The role of inflammation in atrial fibrillation.

Boos CJ, Lip GY. Boos CJ, et al. Int J Clin Pract. 2005 Aug;59(8):870-2. doi: 10.1111/j.1368-5031.2005.0599b.x. Int J Clin Pract. 2005. PMID: 16033603 No abstract available.

8

Ximelagatran for stroke prevention in atrial fibrillation.

Boos CJ, Lip GY. Boos CJ, et al. Expert Rev Cardiovasc Ther. 2005 Jul;3(4):551-63. doi: 10.1586/14779072.3.4.551. Expert Rev Cardiovasc Ther. 2005. PMID: 16076267 Review.

9

Ximelagatran: a clinical perspective.

Boos CJ, Hinton A, Lip GY. Boos CJ, et al. Eur J Intern Med. 2005 Aug;16(4):267-78. doi: 10.1016/j.ejim.2005.02.005. Eur J Intern Med. 2005. PMID: 16084353

10

Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials.

Boos CJ, Lip GY. Boos CJ, et al. J Hum Hypertens. 2005 Nov;19(11):855-9. doi: 10.1038/sj.jhh.1001933. J Hum Hypertens. 2005. PMID: 16094406 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters